Loading...

Masis Isikbay, MD

Title(s)RESIDENTN, Radiology
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hashim D, Gonzalez-Feliciano AG, Ahearn TU, Pettersson A, Barber L, Pernar CH, Ebot EM, Isikbay M, Finn SP, Giovannucci EL, Lis RT, Loda M, Parmigiani G, Lotan T, Kantoff PW, Mucci LA, Graff RE. Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer. Int J Cancer. 2019 Jul 18. PMID: 31318977.
      View in: PubMed
    2. House L, Seminerio MJ, Mirkov S, Ramirez J, Skor M, Sachleben JR, Isikbay M, Singhal H, Greene GL, Vander Griend D, Conzen SD, Ratain MJ. Metabolism of megestrol acetate in vitro and the role of oxidative metabolites. Xenobiotica. 2018 Oct; 48(10):973-983. PMID: 29050522.
      View in: PubMed
    3. Ericka Ebot, Masis Isikbay, Travis Gerke, Thomas U. Ahearn, Rachel S. Kelly, Svitlana Tyekucheva, Andreas Pettersson, Kathryn L. Penney, Lorelei A. Mucci. Abstract 4236: Gene expression profiling of prostate tissue identifies biological pathways associated with TMPRSS2:ERG gene fusion. 2017 Jul 1; 4236-4236.
      View in: Publisher Site
    4. Zareba P, Flavin R, Isikbay M, Rider JR, Gerke TA, Finn S, Pettersson A, Giunchi F, Unger RH, Tinianow AM, Andersson SO, Andrén O, Fall K, Fiorentino M, Mucci LA. Perineural Invasion and Risk of Lethal Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2017 05; 26(5):719-726. PMID: 28062398.
      View in: PubMed
    5. Kregel S, Chen JL, Tom W, Krishnan V, Kach J, Brechka H, Fessenden TB, Isikbay M, Paner GP, Szmulewitz RZ, Vander Griend DJ. Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74. PMID: 27036029.
      View in: PubMed
    6. Kibel AS, Ahn J, Isikbay M, Klim A, Wu WS, Hayes RB, Isaacs WB, Daw EW. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma. Prostate. 2016 Apr; 76(5):479-90. PMID: 26708993.
      View in: PubMed
    7. Hannah J. Brechka, Masis Isikbay, Raj Bhanvadia, Donald Vander Griend. Abstract 2243: Alterations in the binding of Meis proteins to HoxB13 or to DNA promote prostate cancer progression. 2015 Aug 1; 2243-2243.
      View in: Publisher Site
    8. Reyes EE, Gillard M, Duggan R, Wroblewski K, Kregel S, Isikbay M, Kach J, Brechka H, Weele DJ, Szmulewitz RZ, Griend DJ. Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer. J Transl Sci. 2015 Jul; 1(1). PMID: 26753099.
      View in: PubMed
    9. Tara L. Maginnis, Masis Isikbay, Spencer G. Degerstedt, Timothy J. Luethke, Matthew Ortman. The effects of cheliped autotomy and regeneration on aggression in purple shore crabs (Hemigrapsus nudus). 2015 Jul 4; 48(4):241-251.
      View in: Publisher Site
    10. Reyes EE, VanderWeele DJ, Isikbay M, Duggan R, Campanile A, Stadler WM, Vander Griend DJ, Szmulewitz RZ. Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer. J Transl Med. 2014 Nov 26; 12:313. PMID: 25424879.
      View in: PubMed
    11. Isikbay M, Otto K, Kregel S, Kach J, Cai Y, Vander Griend DJ, Conzen SD, Szmulewitz RZ. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer. 2014 Apr; 5(2):72-89. PMID: 24615402.
      View in: PubMed
    12. David James VanderWeele, Masis Isikbay, Edwin Reyes, Ryan Duggan, Alicia J. Wyche, Walter Michael Stadler, Donald Vander Griend, Russell Zelig Szmulewitz. Feasibility of multimodal molecular characterization of the androgen receptor (AR) in circulating tumor cells (CTCs) from patients with castrate-resistant prostate cancer (CRPC). 2014 Feb 1; 32(4_suppl):133-133.
      View in: Publisher Site
    13. Russell Zelig Szmulewitz, Steve Kregel, Masis Isikbay, Yi Cai, James Lin Chen, Donald J Vander Griend. Androgen receptor independent acquired mechanisms of resistance to enzalutamide in castration-resistant prostate cancer. 2014 Feb 1; 32(4_suppl):129-129.
      View in: Publisher Site
    14. Amelia Ahern-Rindell, Masis Isikbay. A size comparison of beta-galactosidase isolated from fibroblasts from normal and GM1-affected sheep. 2013 Feb 1; 108(2):s17.
      View in: Publisher Site
    15. Amelia Ahern-Rindell, Masis Isikbay, Bethany McInturff, Megan Supinski. Evaluation of GLB1 In a Novel Ovine Model of GM1-Gangliosidosis. 2012 Feb 1; 105(2):s15.
      View in: Publisher Site